Conversely, among those between the ages of 30 and 49, women are more than twice as likely to have used a GLP-1 agonist than their male peers
The deletion of CCL28 results in impaired angiogenesis, whereas the use of recombinant CCL28 protein has therapeutic potential for myocardial and hindlimb ischemia, including that in diabetes
Together, these effects have been documented in experimental systems to modify gene expression patterns in ways that reduce chronic inflammatory signaling and support transitions toward tissue stabilization
Although hair loss isnt an officially listed side effect of GLP-1 drugs a class of medications used to treat obesity and type 2 diabetes, including Wegovy, Ozempic, and Zepbound anecdotal reports and emerging research suggest that its a real phenomenon
In recent years, Ozempic has been in the headlines for its off-label use for weight loss